Barclays Plc - Aug 8, 2022 Form 3 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role: 10%+ Owner
Signature: Suejean Mott
Stock symbol: NERV
Transactions as of: Aug 8, 2022
Transactions value $: $0
Form type: 3
Date filed: 8/10/2022, 02:07 PM
Previous filing: Jul 19, 2022
Next filing: Aug 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NERV	Common Stock, $0.0001 par value per share						408K	Aug 8, 2022	By Barclays Bank PLC
holding	NERV	Common Stock, $0.0001 par value per share						197K	Aug 8, 2022	By Barclays Capital Inc.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

(a) Beneficially owned ordinary shares are comprised in Units, each consisting of one ordinary share (b) Name of Person Filing: (1) Barclays PLC (2) Barclays Bank PLC (controlled by Barclays PLC) (3) Barclays Capital, Inc. (controlled by Barclays PLC) (c) Address of Principal Business Office or, if non, Residence: (1) Barclays PLC 1 Churchill Place London, E14 5HP, England (2) Barclays Bank PLC 1 Churchill Place London, E14 5HP, England (3) Barclays Capital, Inc. 745 7th Avenue New York, New York 10019 United States